Dihydroergotamine
RxNorm 3418
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 3418 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Dihydroergotamine.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Dihydroergotamine
(Atom ID: 12251565)
PTPrescribable
Designated preferred name (PT):
Dihydroergotamine
(Atom ID: 103574)
FNPrescribable
Full form of descriptor (FN):
Dihydroergotamine (substance)
(Atom ID: 103584)
PTPrescribable
Designated preferred name (PT):
Dihydroergotamine-containing product
(Atom ID: 10801348)
FNPrescribable
Full form of descriptor (FN):
Product containing dihydroergotamine (medicinal product)
(Atom ID: 9256186)
Patient Education
Dihydroergotamine Injection and Nasal Spray
Dihydroergotamine is used to treat migraine headaches. Dihydroergotamine is in a class of medications called ergot alkaloids. It works by tightening blood vessels in the brain and by stopping the release of natural substances in the brain that cause swelling.
[Learn More]
* Please review the disclaimer below.